Cannabis firm Trulieve forecasts at least $250M in 2026 operating cash flow as U.S. policy shifts fuel uplisting prospects.
Trulieve Cannabis Corp. expects to generate at least $250M in operating cash flow by 2026, driven by recent U.S. regulatory moves. The company cited President Trump’s cannabis reform actions and Attorney General Todd Blanche’s reclassification of medical marijuana as key catalysts.
The projection follows a quarter where management emphasized policy changes as a turning point for the sector. Trulieve is also exploring an uplisting to a major U.S. exchange, which could broaden investor access and liquidity.
No immediate market reaction was disclosed, but the outlook reflects growing optimism in the cannabis industry amid federal reforms.